← Back to all trials
Completed
NCT05755750
Intratendinous Genipin Injection in Horses With Tendon Injuries
Conditions: Superficial Digital Flexor Tendonitis
Sex: All
Phase: PHASE3
Enrollment: 74
Sponsor: University of Zurich
Location: Switzerland
Summary
Our study is the first to use genipin, a naturally occurring collagen cross-linking agent, as a therapeutic agent to treat superficial digital flexor tendon (SDFT) injuries in horses.
The promising approach of intratendinous genipin injection and tendon mechanical enhancement could be a viable alternative to current therapies for SDFT injuries.
Eligibility Criteria
Inclusion Criteria:clinical and sonographic evidence of a tendon injuryExclusion Criteria:in the final analysis, only superficial digital flexor tendon injuries were includedif follow-up was less than 12 m due to euthanasia, death or other reasons, horses were excluded from the study
Source: ClinicalTrials.gov (NCT05755750). StuddyBuddy aggregates publicly available trial information.